A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Venus Concept Inc. (referred to herein, together with its subsidiaries unless the context otherwise denotes, as the “Company,” “Venus Concept,” “us,” “our,” or “we”) is an innovative global medical technology company that develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. Our systems have been designed on cost-effective, proprietary and flexible platforms that enable us to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas. In the years ended December 31, 2024 and 2023, respectively, a substantial majority of our systems delivered in North America were in non-traditional markets. We have had recurring net operating losses and negative cash flows from operations.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 59M | 65M | 76M | 99M | 106M | 78M |
| Net Income | -55M | - | - | -44M | -23M | -85M |
| EPS | $-40.31 | $-71.21 | $-68.47 | $-109.34 | $-69.30 | $-384.45 |
| Free Cash Flow | -21M | -11M | -13M | -27M | -20M | -29M |
| ROIC | -817.4% | - | - | -56.0% | -19.5% | -71.2% |
| Gross Margin | 64.4% | 68.3% | 68.3% | 66.3% | 70.2% | 65.9% |
| Debt/Equity | 1.87 | 13.27 | -5.05 | 8.65 | 1.89 | 1.71 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -35M | -27M | -28M | -35M | -15M | -68M |
| Operating Margin | -59.0% | -41.9% | -37.1% | -35.1% | -14.0% | -87.0% |
| ROE | -2043.2% | - | - | -540.0% | -56.2% | -192.8% |
| Shares Outstanding | 2M | 1M | 1M | 0M | 0M | 0M |
Venus Concept Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 67.8%.
Venus Concept Inc. (VERO) has a 5-year average return on invested capital (ROIC) of -48.9%. This is below average and may indicate limited pricing power.
Venus Concept Inc. (VERO) has a market capitalization of $614K. It is classified as a small-cap stock.
Venus Concept Inc. (VERO) does not currently pay a regular dividend.
Venus Concept Inc. (VERO) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
Venus Concept Inc. (VERO) reported annual revenue of $65 million in its most recent fiscal year, based on SEC EDGAR filings.
Venus Concept Inc. (VERO) generated $-11 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Venus Concept Inc. (VERO) has a debt-to-equity ratio of 13.27. This indicates higher leverage, which may increase financial risk.
Venus Concept Inc. (VERO) reported earnings per share (EPS) of $-71.21 in its most recent fiscal year.
Venus Concept Inc. (VERO) has a 5-year average gross margin of 67.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 9 years of financial data for Venus Concept Inc. (VERO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Venus Concept Inc. (VERO) has a book value per share of $3.34, based on its most recent annual SEC filing.
No recent press releases.